October 07, 2022
2 min read
Source/Disclosures
Salpekar J. Examining cannabinoids in the epilepsy treatment spectrum. Presented at: BRAINWeek; Sept. 28-30, 2022; Las Vegas.
Disclosures:
Salpekar reports performing contracted research for Jazz Pharmaceuticals.
LAS VEGAS — Cannabinoids have been shown to effectively control seizures across the epilepsy spectrum; however, quality control of products remains a challenge, according to a presenter at BRAINWeek 2022.
“We’re not really helped by the medical establishment, or government, or anybody else,” Jay Salpekar, MD, associate professor of psychiatry and neurology at Johns Hopkins University School of Medicine and director of neuropsychiatry in the epilepsy program at Kennedy Krieger Institute, said during the presentation. “That’s the thing that rang true with parents, with their kids and epilepsies, things stopped working. They’ve had to try something different.”
Another obstacle, Salpekar said, is that there is an overrepresentation of psychiatric…
